Figure 5. Cost effectiveness acceptability curve for higher intensity statin compared with a lower intensity statin in a 65 year old patient with stable coronary artery disease.

Figure 5Cost effectiveness acceptability curve for higher intensity statin compared with a lower intensity statin in a 65 year old patient with stable coronary artery disease

Our model shows that using a threshold of £20,000/QALY, high intensity is 94% cost-effective when compared with low intensity statins in patients with stable CAD.

From: Appendix C, Health Economic Modelling

Cover of Lipid Modification
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease [Internet].
NICE Clinical Guidelines, No. 67.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce anypart of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.